Overview

GLAND PHARMA LTD is an active pharmaceutical ingredient (API) supplier with 69 active FDA Type II Drug Master Files, covering ACETAZOLAMIDE; ARGATROBAN MONOHYDRATE (PROCESS-II); ARGATROBAN MONOHYDRATE USP; ARIPIPRAZOLE LAUROXIL – STERILE; ARIPIPRAZOLE MONOHYDRATE – STERILE; ATRACURIUM BESYLATE USP.

Core services & business areas

API Manufacturing

Active pharmaceutical ingredients supplied

Substances GLAND PHARMA LTD is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

GLAND PHARMA LTD holds 69 active (69 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • PRALATREXATEActive2025-09-29
  • ISAVUCONAZONIUM SULFATEActive2025-06-13
  • DANTROLENE SODIUMActive2024-03-29
  • LEVOCARNITINEActive2023-11-27
  • FOSAPREPITANT DIMEGLUMINEActive2023-09-29
  • EPINEPHRINE (LOW EPIMER)Active2023-09-27
  • MANGANESE SULFATEActive2022-12-30
  • CUPRIC SULFATEActive2022-12-23
  • LINEZOLIDActive2022-11-30
  • ACETAZOLAMIDEActive2022-10-31
  • CYSTEAMINE HYDROCHLORIDEActive2022-08-30
  • SELENIOUS ACIDActive2022-08-24
  • CHLOROTHIAZIDEActive2022-06-30
  • REGADENOSON (PROCESS – II)Active2022-06-24
  • PROTAMINE SULFATEActive2021-12-29

Showing 15 of 69 Drug Master Files.

FDA compliance signals

31 FDA enforcement records linked to this company.

  • 4832024-07-25

    Record maintenance 1 year (except exempt OTC)

  • 4832024-07-25

    Procedures not in writing, fully followed

  • 4832023-07-14

    Complete test data included in records

  • 4832019-11-07

    Scientifically sound laboratory controls

  • 4832019-11-07

    Written record of investigation incomplete

  • 4832019-11-07

    Equipment for Environmental Control

  • 4832019-11-07

    Representative Samples

  • 4832019-11-01

    Written record of investigation incomplete

  • 4832019-11-01

    Validation lacking for sterile drug products

  • 4832019-05-16

    Written procedures lacking for use of pesticides etc.

  • 4832019-05-16

    Environmental Monitoring System

  • 4832019-05-16

    Cleaning SOPs/schedules

  • 4832019-05-16

    Scientifically sound laboratory controls

  • 4832019-05-16

    Written procedures fail to include

  • 4832019-05-16

    Written record of investigation incomplete

Verified Supplier Partner

Is this GLAND PHARMA LTD? Get in front of buyers actively sourcing.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.